Filter your results
- 3
- 1
- 4
- 4
- 1
- 1
- 1
- 1
- 4
- 2
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 4
- 3
- 2
- 2
- 2
- 2
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
|
|
sorted by
|
|
Heterogeneity in response to serological exposure markers of recent Plasmodium vivax infections in contrasting epidemiological contextsPLoS Neglected Tropical Diseases, 2021, 15 (2), pp.e0009165. ⟨10.1371/journal.pntd.0009165⟩
Journal articles
hal-03258592v1
|
||
|
A Worldwide Map of Plasmodium falciparum K13-Propeller Polymorphisms.New England Journal of Medicine, 2016, 374 (25), pp.2453-64. ⟨10.1056/NEJMoa1513137⟩
Journal articles
pasteur-01336483v1
|
||
|
Development and validation of serological markers for detecting recent Plasmodium vivax infectionNature Medicine, 2020, 26 (5), pp.741-749. ⟨10.1038/s41591-020-0841-4⟩
Journal articles
pasteur-02612720v1
|
||
|
Worldwide sequence conservation of transmission-blocking vaccine candidate Pvs230 in Plasmodium vivax.Vaccine, 2011, 29 (26), pp.4308-15. ⟨10.1016/j.vaccine.2011.04.028⟩
Journal articles
pasteur-00835696v1
|